Brief Review Illicit Use of Modem Volatile Anaesthetics

Total Page:16

File Type:pdf, Size:1020Kb

Brief Review Illicit Use of Modem Volatile Anaesthetics 76 Brief Review Illicit use of modem M. Yamashita MD, A. Matsuki MD, T. Oyama MD volatile anaesthetics Sixteen reported cases of abuse of modern volatile anaes- Case reports thetics are summarized. Twelve of the sixteen subjects The reported cases are summarized in the Table. died. Halothane was ingested or injected intravenously Four typical cases are presented. for s~icidal purpose, and sniffed for mood elevation. 1. Ingestion of halothane for suicidal purpose. Abuse of raodern volatile anaesthetics deserves more A 48-year-old female (patient 1) ingested 250 ml attention than it has received M the past. of halothane for suicidal purpose. The patient was comatose when brought to hospital. She vomited Key words food remains which smelled strongly of halothane. ANAESTHETICS, VOLATILE: halothane, enflurane, Cardiac arrest occurred following aspiration of the abuse. SUICIDE: vomitus. She was successfully resuscitated and mechanically ventilated, One hour and fifty minutes after admission, the patient regained consciousness and obeyed simple orders, and began to "fight" the ventilator. The endotracheal tube was removed. Drug abuse among hospital personnel ~-s especially However, one hour later, the blood pressure had anaesthesia personnel 6-8 has been identified as a fallen to 70 nunHg, consciousness was lost, and the major problem. Ward and Saidman 8 reported 325 patient was reintubated. After 36 hours of mechani- instances of narcotic abuse among anaesthesia cal ventilation, she gained consciousness. Subse- personnel, and 30 deaths secondary to drug abuse in quently, she was weaned from the ventilator and 235 confirmed cases. discharged from the hospital in two weeks. At Alcohol, narcotics, barbiturates, tranquilizers, follow ap examination, no abnormalities in liver and nitrous oxide have been implicated in these function tests were documented. 1o reports, t-s with less attention to volatile anaes- 2. Intravenous injection of halothane for suicidal thetics. purpose. Modern volatile anaesthetics have also been A 42-year-old man (patient 4) was admitted to abused, 9-j9 most commonly by operating room hospital within an hour of intravenous self-admini- personnel. 11-13"~s Several deaths due to halo- stration of 9 ml of liquid halothane. He was coma- thanr t.12.14-1s and enflurane 13 abuse have been tose and cyanotic. There were extensive crepita- reported. By reviewing these reported cases, we tions over both lung fields. The patient was treated hope to draw to the anaesthetists' attention the illi- with mechanical ventilation, with 5 cm H20 of cit use of modem volatile anaesthetics, before it PEEP. becomes beyond our control. Although his level of consciousness improved transiemly, he became hypotensive with peripheral vasoconstriction and profound sinus bradycardia, followed by asystole. Autopsy showed grossly From the Department of Anaesthesiology, Hkosaki oedematous lungs. 18 University, School of Medicine, Hirosaki, Japan. 3. Sniffing of halothane for a "high" sensation. Address correspondence to: M. Yamashita MD, A 26-year-old male anaesthetist (patient 6) was Department of Anaesthesiology, Hirosaki University, found dead in the prone position on a mattress at School of Medicine, Hirosald, 036, Japan. home. He was holding a 25 x 30 cm polyvinyl bag CAN ANAESTH SOC J 1984 i 31: I ! pp76-79 TABLE Reported eases of abuse Blood Patient Age Made of concentration Reference no. (years) Sex Occupation AgetJt administration Purpose Outcome (mgLIOOml) no. 1 48 F ? Halotharte Ingestion Suicide Recovered ] 0 2 28 M ? Halothane Ingestion Suicide Recovered 10 3 19 M Hospital employee Halothane Ingestion Suicide Died 65 14 4 42 M ? Halothai~ Intravenous injection Died 0.79 18 5 42 M Surgeon Halothane Sniffing Mood elevation Died 11 6 26 M Anaesthetisl Halothane Sniffing Mood elevation Died 20 11 7 24- M OR technician H~lothane Sniffing Died 15 8 28 M ER technician Halothane Sniffing Died 15 9 22 M OR technician Halothane Sniffing Died 15 10 21 M ? Halothane Sniffing Died 16, 17 11 20 M Navy corpsman Halothane Sniffing (?) Died 16, 17 12 19 M ? Halothanc Open-drop Died 20 9 13 25 F OR technician Halothane Sniffing Mood elevation Died 12 14 25 F OR technician Halothane Sniffing Recovered 12 15 23 F OR technician Halothane Sniffing Recovered 12 ] 6 29 F Student nurse Enflurane Topical application Treatnaent of Died 13 anaesthetist Herpes Simplex Labialis 78 CANADIAN ANAESTHETISTS ' SOCIETY JOURNAL with a gauze pad in it at his mouth. He was a known sedatives;6 however, it can be predicted that this alcoholic and halothane abuser. The halothane incidence of abuse of volatile anaesthetics will concentration in the blood at autopsy was 20rag/ increase. Abuse of narcotics and sedatives is now 100ml. II widely known, and strict control of these drugs will 4. Misuse of enflurane. force the abusers to seek alternative drugs. They A 29-year-old student nurse anaesthetist (patient may find halothane or enflurane good alternatives, 16) obtained a full 250 ml bottle of enflurane and for since at present volatile anaesthetics are not care- the next three hours was observed with a gauze pad fully controlled, and practically anyone in an to which she had applied the enflurane. She believed operating room can remove a bottle of halothane or that the topical application of enflurane might cure enflurane. Nitrous oxide has been widely abused, herpes simplex on her lower lip. About an hour especially among dentists, and student dentists,4'~ later, she was found in a women's rest room but the volatile anaesthetics, packaged in small slumped over while sitting on a commode. Her bottles, are much easier to carry away than a heavy forearms were crossed on her knees and her head nitrous oxide cylinder. rested on her forearms over her lap. The enflurane The danger of abuse of modem volatile anaes- bottle was empty. Resuscitation was unsuccessful. thetics requires careful control of drugs, As Spencer Autopsy findings were normal except that appre- and Raasch 16'17 state, it is important that every ciable amounts of enflurane were found in the skin, effort be made to prevent future deaths from abuse gastric contents, blood and lung. t3 of modem volatile anaesthetics. First, everyone associated with the clinical use of these agents must Discussion be aware of the potential for abuse and the occur- Halothane was ingested for suicidal purpose by rence of sudden death during abuse. Secondly, an three patients (1,2, 3) and injected intravenously by educational effor~ should be made to acquaint patient 4. Patients 1 and 2 ingested 250 mt of medical personnel with the danger of abuse of these halothane, but recovered, while patient 3 ingested agents. Thirdly, access to these drugs should be only 35 ml but died. This suggests that even when a restricted to anaesthetists for their immediate use. patient has ingested 250 ml of halothane, if the Abuse of modern volatile anaesthetics deserves timing and treatment are appropriate, survival is more attention than it has received in the past. possible. Absorption of halothane continues from the gastrointestinal tract, therefore mechanical Addendum hyperventilation, hastening pulmonary elimination Since completion of this review, an additional case of halothane must be instituted. 1~ Intravenously has been reported. A 35-year old hospital technician injected halothane is very toxic, damages pulmo- ingested halothane and lapsed into coma. He nary vessels and leads to acute pulmonary oedema recovered uneventfully following intensive suppor- and death. In'2~ tive care. Some subjects sniffed halothane in order to get a "high" sensation~ 11 , 12 Several died, probably due to (Wig J, Chakravarty S, Krishnanmrthy K, Mehla D airway obstruction or cardiac arrhythmias.l 1.15-17,19 Coma following ingestion of halothane. Its successful Habitual sniffing of halothane has been reported to management. Anaesthesia 1983; 38: 552-5.) induce "hepatitis", 12 and a death due to hepatic failure. 12 We must pay more attention to the illicit use of References volatile anaesthetics, since in addition to these case 1 AMA Counci! on Mental Health. The sick physician- reports of abuse, numerous unreported cases likely impairment by psychiatric disorders, including alco- exist. Most of the reported abusers are hospital- holism and drug dependence. JAMA 1973; 223: related personnel, such as operating-room tech- 684-7. nicians, emergency-room technicians, student nurse 2 Bressler B. Suicide and drag abuse in the medical anaesthetists, surgeons, and anaesthetists. The cur- community. Suicide Life Threat Behav 19761 6: rent incidence of abuse of volatile anaesthetics 169-78. appears low compared to abuse of narcotics or 3 GreenRC, Jr, CarroltJG, Buxton WD. Drug addle- Yamasbita elal.: ILLICIT USE OF MODERN VOLATILE ANAESTHETICS 79 tion among physicians. The Virginia experience. Rtsum6 3AMA 1976; 236: 1372-5. On rapporte 16 cas d'abus d'agents anesth3siques 4 Rosenberg 1t, Orkin FK, Springstead J. Abuse of volatils modernes. Douze des 16 patients sont ddcdd~s. nitrous oxide. Anesth Analg 1979; 58: 104-6. L'halothane a 3t~ ingdr~ ou auto-inject3 par vole intra- 5 Paulson GW. "Recreational" misuse of nitrous veineuse dans un but suicidaire ou inhal~ pour provoquer oxide. ~I Am Dent Assoc i979; 98: 410-1. une sensation de bien-drre. On pense que l'abus des 6 Gravenstein JS, Kory WP, Mark.~ RG. Drag abuse agents d'inhalation modernes m3rite plus d'attention by anesthesia personnel. Anesth Analg 1983; 62: qu'il ne lui en a dt~ accord3 duns le passe. 467-72. 7 Farley WJ, Talbott GD. Anesthesiology and addic- tion~ Anesth Analg t983; 62:465-6 8 WardCF, SaidmanLt. Controllcdsabstancesabuse: a survey of training programs 1970-1980; final results and comment. Anesthesiology 1981; 55: A346. 9 Block S. Rosenblatt R. A halothane-abuse fatality. Anesthesiology 1980; 52: 524. 10 Curelaru l, Stanciu ST, Nicolau V, Fuhrer H, llliescu M. A case of recovery, from coma produced by the ingestion of 250 rrd of halothane.
Recommended publications
  • Management of Chronic Problems
    MANAGEMENT OF CHRONIC PROBLEMS INTERACTIONS BETWEEN ALCOHOL AND DRUGS A. Leary,* T. MacDonald† SUMMARY concerned. Alcohol may alter the effects of the drug; drug In western society alcohol consumption is common as is may change the effects of alcohol; or both may occur. the use of therapeutic drugs. It is not surprising therefore The interaction between alcohol and drug may be that concomitant use of these should occur frequently. The pharmacokinetic, with altered absorption, metabolism or consequences of this combination vary with the dose of elimination of the drug, alcohol or both.2 Alcohol may drug, the amount of alcohol taken, the mode of affect drug pharmacokinetics by altering gastric emptying administration and the pharmacological effects of the drug or liver metabolism. Drugs may affect alcohol kinetics by concerned. Interactions may be pharmacokinetic or altering gastric emptying or inhibiting gastric alcohol pharmacodynamic, and while coincidental use of alcohol dehydrogenase (ADH).3 This may lead to altered tissue may affect the metabolism or action of a drug, a drug may concentrations of one or both agents, with resultant toxicity. equally affect the metabolism or action of alcohol. Alcohol- The results of concomitant use may also be principally drug interactions may differ with acute and chronic alcohol pharmacodynamic, with combined alcohol and drug effects ingestion, particularly where toxicity is due to a metabolite occurring at the receptor level without important changes rather than the parent drug. There is both inter- and intra- in plasma concentration of either. Some interactions have individual variation in the response to concomitant drug both kinetic and dynamic components and, where this is and alcohol use.
    [Show full text]
  • Pharmacology – Inhalant Anesthetics
    Pharmacology- Inhalant Anesthetics Lyon Lee DVM PhD DACVA Introduction • Maintenance of general anesthesia is primarily carried out using inhalation anesthetics, although intravenous anesthetics may be used for short procedures. • Inhalation anesthetics provide quicker changes of anesthetic depth than injectable anesthetics, and reversal of central nervous depression is more readily achieved, explaining for its popularity in prolonged anesthesia (less risk of overdosing, less accumulation and quicker recovery) (see table 1) Table 1. Comparison of inhalant and injectable anesthetics Inhalant Technique Injectable Technique Expensive Equipment Cheap (needles, syringes) Patent Airway and high O2 Not necessarily Better control of anesthetic depth Once given, suffer the consequences Ease of elimination (ventilation) Only through metabolism & Excretion Pollution No • Commonly administered inhalant anesthetics include volatile liquids such as isoflurane, halothane, sevoflurane and desflurane, and inorganic gas, nitrous oxide (N2O). Except N2O, these volatile anesthetics are chemically ‘halogenated hydrocarbons’ and all are closely related. • Physical characteristics of volatile anesthetics govern their clinical effects and practicality associated with their use. Table 2. Physical characteristics of some volatile anesthetic agents. (MAC is for man) Name partition coefficient. boiling point MAC % blood /gas oil/gas (deg=C) Nitrous oxide 0.47 1.4 -89 105 Cyclopropane 0.55 11.5 -34 9.2 Halothane 2.4 220 50.2 0.75 Methoxyflurane 11.0 950 104.7 0.2 Enflurane 1.9 98 56.5 1.68 Isoflurane 1.4 97 48.5 1.15 Sevoflurane 0.6 53 58.5 2.5 Desflurane 0.42 18.7 25 5.72 Diethyl ether 12 65 34.6 1.92 Chloroform 8 400 61.2 0.77 Trichloroethylene 9 714 86.7 0.23 • The volatile anesthetics are administered as vapors after their evaporization in devices known as vaporizers.
    [Show full text]
  • Appendix D: Important Facts About Alcohol and Drugs
    APPENDICES APPENDIX D. IMPORTANT FACTS ABOUT ALCOHOL AND DRUGS Appendix D outlines important facts about the following substances: $ Alcohol $ Cocaine $ GHB (gamma-hydroxybutyric acid) $ Heroin $ Inhalants $ Ketamine $ LSD (lysergic acid diethylamide) $ Marijuana (Cannabis) $ MDMA (Ecstasy) $ Mescaline (Peyote) $ Methamphetamine $ Over-the-counter Cough/Cold Medicines (Dextromethorphan or DXM) $ PCP (Phencyclidine) $ Prescription Opioids $ Prescription Sedatives (Tranquilizers, Depressants) $ Prescription Stimulants $ Psilocybin $ Rohypnol® (Flunitrazepam) $ Salvia $ Steroids (Anabolic) $ Synthetic Cannabinoids (“K2”/”Spice”) $ Synthetic Cathinones (“Bath Salts”) PAGE | 53 Sources cited in this Appendix are: $ Drug Enforcement Administration’s Drug Facts Sheets1 $ Inhalant Addiction Treatment’s Dangers of Mixing Inhalants with Alcohol and Other Drugs2 $ National Institute on Alcohol Abuse and Alcoholism’s (NIAAA’s) Alcohol’s Effects on the Body3 $ National Institute on Drug Abuse’s (NIDA’s) Commonly Abused Drugs4 $ NIDA’s Treatment for Alcohol Problems: Finding and Getting Help5 $ National Institutes of Health (NIH) National Library of Medicine’s Alcohol Withdrawal6 $ Rohypnol® Abuse Treatment FAQs7 $ Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Keeping Youth Drug Free8 $ SAMHSA’s Center for Behavioral Health Statistics and Quality’s (CBHSQ’s) Results from the 2015 National Survey on Drug Use and Health: Detailed Tables9 The substances that are considered controlled substances under the Controlled Substances Act (CSA) are divided into five schedules. An updated and complete list of the schedules is published annually in Title 21 Code of Federal Regulations (C.F.R.) §§ 1308.11 through 1308.15.10 Substances are placed in their respective schedules based on whether they have a currently accepted medical use in treatment in the United States, their relative abuse potential, and likelihood of causing dependence when abused.
    [Show full text]
  • Newborn Anaesthesia: Pharmacological Considerations D
    $38 REFRESHER COURSE OUTLINE Newborn anaesthesia: pharmacological considerations D. Ryan Cook MD Inhalation anaesthetics Several investigators have studied the age-related For the inhalation anaesthetics there are age-related cardiovascular effects of the potent inhalation differences in uptake and distribution, in anaes- anaesthetics at known multiples of MAC. At thetic requirements as reflected by differences in end-tidal concentrations of halothane bracketing MAC, in the effects on the four determinants of MAC, Lerman er al. 2 noted no difference in the cardiac output (preload, afterload, heart rate and incidence of hypotension or bradycardia in neonates contractility), and in the sensitivity of protective and in infants one to six months of age. Likewise, cardiovascular reflexes (e.g., baroreceptor reflex). we 3 have noted no age-related differences in the These differences limit the margin of safety of the determinants of cardiac output in developing piglets potent agents in infants. 1-20 days during either halothane or isoflurane Alveolar uptake of inhalation anaesthetics and anaesthesia. Halothane produced hypotension by a hence whole-body uptake is more rapid in infants reduction in contractility and heart rate; in much than in adults. J Lung washout is more rapid in older animals halothane also decreases peripheral infants than in adults because of the larger ratio vascular resistance. In piglets although blood pres- between alveolar minute ventilation and lung sure was equally depressed with isoflurane and volume (FRC) (3.5:1 in the infant vs. 1.3:1 in the halothane, cardiac output was better preserved adult). Increased brain size (ml.kg-J), limited during isoflurane anaesthesia.
    [Show full text]
  • STUDIES with NON-STEROIDAL ANTI-INFLAMMATORY DRUGS By
    STUDIES WITH NON-STEROIDAL ANTI-INFLAMMATORY DRUGS by Elizabeth Ann Galbraith M.Sc., C.Biol., M.I.Biol. A thesis submitted for the degree of Doctor of Philosophy in the Faculty of Veterinary Medicine of the University of Glasgow Department of Veterinary Pharmacology M ay 1994 ProQuest Number: 11007888 All rights reserved INFORMATION TO ALL USERS The quality of this reproduction is dependent upon the quality of the copy submitted. In the unlikely event that the author did not send a com plete manuscript and there are missing pages, these will be noted. Also, if material had to be removed, a note will indicate the deletion. uest ProQuest 11007888 Published by ProQuest LLC(2018). Copyright of the Dissertation is held by the Author. All rights reserved. This work is protected against unauthorized copying under Title 17, United States C ode Microform Edition © ProQuest LLC. ProQuest LLC. 789 East Eisenhower Parkway P.O. Box 1346 Ann Arbor, Ml 48106- 1346 4kh! TUT GLASGOW UNIVERSITY ) LIBRARY i To Ian ii TABLE OF CONTENTS Acknowledgements v Declaration vi Summary vii List of tables xi List of figures xv Abbreviations xvii Chapter 1 - General Introduction 1 Chapter 2 - General Material and Methods 29 Chapter 3 - Studies with Flunixin 3.1 Introduction 43 3.2 Experimental Objectives 44 3.3 Materials and Methods 45 3.4 Experiments with Flunixin 48 3.5 Results of Oral Experiments with Flunixin 49 3.6 Results of Intravenous Experiments with Flunixin 53 3.7 Results of Subcutaneous Experiments with Flunixin 55 3.8 Discussion 57 3.9 Tables and Figures
    [Show full text]
  • Objective Salicylate Propionic Acid Derivatives Acetic Acid
    Semester-IV Sub Name-medicinal chemistry-I (sub code-BP-402T) Objective Sodium salicylate, Aspirin, Mefenamic acid*, Meclofenamate, Indomethacin, Sulindac, Tolmetin, Zomepriac, Diclofenac, Ketorolac, Ibuprofen*, Naproxen, Piroxicam, Phenacetin, Acetaminophen, Antipyrine, Phenylbutazone. 1. INTRODUCTION A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti- inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions. Some anti-inflammatory agents are being studied in the prevention and treatment of cancer. 1.1 CLASSIFICATION NSAIDs can be classified based on their chemical structure or mechanism of action. Older NSAIDs were known long before their mechanism of action was elucidated and were for this reason classified by chemical structure or origin. Newer substances are more often classified by mechanism of action. Salicylate • Aspirin (acetylsalicylic acid) • Diflunisal (Dolobid) • Salicylic acid and its salts Propionic acid derivatives • Ibuprofen • Dexibuprofen • Naproxen • Fenoprofen • Ketoprofen • Dexketoprofen Acetic acid derivatives • Indomethacin • Tolmetin • Sulindac • Ketorolac • Diclofenac • Aceclofenac • Nabumetone (drug itself is non-acidic but the active, principal metabolite has a carboxylic acid group) Enolic acid (oxicam) derivatives • Piroxicam • Meloxicam • Tenoxicam • Droxicam • Lornoxicam • Isoxicam (withdrawn from market 1985) • Phenylbutazone Anthranilic acid derivatives (fenamates) The following NSAIDs are
    [Show full text]
  • World Health Organization Model List of Essential Medicines, 21St List, 2019
    World Health Organizatio n Model List of Essential Medicines 21st List 2019 World Health Organizatio n Model List of Essential Medicines 21st List 2019 WHO/MVP/EMP/IAU/2019.06 © World Health Organization 2019 Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo). Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic edition”. Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the World Intellectual Property Organization. Suggested citation. World Health Organization Model List of Essential Medicines, 21st List, 2019. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO. Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
    [Show full text]
  • Comparison of Sevoflurane and Halothane Masaki Yurino MD Phl), Hitomi Kirnura MD
    440 Vital capacity rapid inhalation induction technique: comparison of sevoflurane and halothane Masaki Yurino MD Phl), Hitomi Kirnura MD Induction of anaesthesia using the vital capacity rapid inhal- de cette dpreuve et chacun d'eux a refu un des deux agents: ation induction (VCRI1) technique with either sevoflurane or 17 ont refu le sdvoflurane et 15, l~alothane. Non pr~m~diquds, halothane was compared. The induction time, characteristics, ils ont inspir~ approximativement 2,6 fois l~quivalent de la and acceptability were assessed. Thirty-two volunteers were concentration alvdolaire minimum (CAM) de l'un ou de l'autre given one of the vapours: 17 received sevoflurane and 15 halo- des agents. II n'y avait de differences entre les parambtres cardio- thane. Subjects were unpremedicated and breathed approxi- vasculaires et respiratoires. La dur~e moyenne de l'induction mately 2.6 • minimum alveolar concentration (MAC) equiv- de l'anesth~sie avec l'halothane (153 + 46 sec, SD) a dtd plus alent of either agent. There were no differences in the patients' lente que celle produite par le s~voflurane (81 + 22 sec, SD, cardiovascular or respiratory variables. The mean time for in- P < 0,05), ce qui reflbte son coefficient de solubilit$ sang:gaz duction of anaesthesia with halothane (153 + 46 sec, SD) was plus dlev~. L~ncidence des complications telles que la toux et slower than with sevoflurane (81 + 22 sec, SD, P < 0.05), les mouvements a dt~ moindre avec s$voflurane qu'avec l~a- reflecting its higher blood:gas solubility. There were fewer in- lothane.
    [Show full text]
  • Pharmacology
    STATE ESTABLISHMENT «DNIPROPETROVSK MEDICAL ACADEMY OF HEALTH MINISTRY OF UKRAINE» V.I. MAMCHUR, V.I. OPRYSHKO, А.А. NEFEDOV, A.E. LIEVYKH, E.V.KHOMIAK PHARMACOLOGY WORKBOOK FOR PRACTICAL CLASSES FOR FOREIGN STUDENTS STOMATOLOGY DEPARTMENT DNEPROPETROVSK - 2016 2 UDC: 378.180.6:61:615(075.5) Pharmacology. Workbook for practical classes for foreign stomatology students / V.Y. Mamchur, V.I. Opryshko, A.A. Nefedov. - Dnepropetrovsk, 2016. – 186 p. Reviewed by: N.I. Voloshchuk - MD, Professor of Pharmacology "Vinnitsa N.I. Pirogov National Medical University.‖ L.V. Savchenkova – Doctor of Medicine, Professor, Head of the Department of Clinical Pharmacology, State Establishment ―Lugansk state medical university‖ E.A. Podpletnyaya – Doctor of Pharmacy, Professor, Head of the Department of General and Clinical Pharmacy, State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ Approved and recommended for publication by the CMC of State Establishment ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ (protocol №3 from 25.12.2012). The educational tutorial contains materials for practical classes and final module control on Pharmacology. The tutorial was prepared to improve self-learning of Pharmacology and optimization of practical classes. It contains questions for self-study for practical classes and final module control, prescription tasks, pharmacological terms that students must know in a particular topic, medical forms of main drugs, multiple choice questions (tests) for self- control, basic and additional references. This tutorial is also a student workbook that provides the entire scope of student’s work during Pharmacology course according to the credit-modular system. The tutorial was drawn up in accordance with the working program on Pharmacology approved by CMC of SE ―Dnipropetrovsk medical academy of Health Ministry of Ukraine‖ on the basis of the standard program on Pharmacology for stomatology students of III - IV levels of accreditation in the specialties Stomatology – 7.110105, Kiev 2011.
    [Show full text]
  • Introduction and Definition Criteria for Evaluating Methods of Euthanasia Indications for Euthanasia Methods of Euthanasia
    EUTHANASIA Lyon Lee DVM PhD DACVA Introduction and definition • Many of the contents presented here are excerpts from 2000 Report of the AVMA Panel on Euthanasia (JAVMA 218 (5), 2001) • Euthanasia is a word of Greek origin, a rough translation being Good death o Webster English Dictionary The act or practice of painlessly putting to death o Oxford English Dictionary The action of inducing a gentle and easy death o Good death is one that occurs with minimal pain and distress o Euthanasia is, therefore, an act of inducing death in hopelessly unwell or injured animals in a pain free manner on the grounds of humanity Criteria for evaluating methods of euthanasia • It must be painless and not induce fear or apprehension in the animal • It must be reliable • It must be rapid • It must be safe and simple to operate • It must be nonreversible • It should be inexpensive • It should as far as possible be aesthetic • It should be possible to observe the animals at all times • It should be safe for predators/consumers should the carcass be consumed Indications for euthanasia • Required as an experimental procedure • Sustained a severe injury that is difficult to manage • The animal is in excruciating pain refractory to the treatment • On demand by the authority (State or Federal inspectors, IACUC etc.) • The colony may be at risk by an infected individual • On economic grounds • Approved for a research project to terminate the life Methods of euthanasia • The methods can be divided into physical or chemical methods • Physical methods o Stunning
    [Show full text]
  • Downloaded from Bioscientifica.Com at 09/24/2021 09:13:46AM Via Free Access 262 W PEI and Others $ Aging, Osteoprogenitors and Progesterone Receptors
    261 Effect of age on progesterone receptor expression, and osteoprogenitor proliferation and differentiation in female rat vertebral cell populations Weidong Pei, Carlton G Bellows, Yongheng Jia and Johan N M Heersche Faculty of Dentistry, University of Toronto, 124 Edward Street, Toronto, Ontario M5G 1G6, Canada (Requests for offprints should be addressed to W Pei; Email: [email protected]) Abstract In the present investigation, we evaluated whether the capacity PR-A expression in cell populations from the 3 and 18 months for proliferation and differentiation of progesterone (Prog)- old rats, but had no effect on PR-A expression in cell dependent osteoprogenitors in the female rat skeleton is related populations from 22$5, 25$5, and 26 months old rats. This to the level of Prog receptors (PRs) and/or the level of might be related to the high basal expression of PR in 22$5–26 circulating estrogen. We confirmed that in rats, estrogen levels months old rats (the ‘persistent estrous’ phase). Our results also at 18 months of age are higher than those at 3 months, and confirm our previous observation that in rats, the number of higher again in rats of 22$5, 25$5, and 26 months of age. Prog Prog- and dexamethasone (Dex)- dependent osteoprogeni- levels in rats of ages between 18 and 25$5 months were lower tors, and the effect of estrogen on the response to Prog do not than those at 26 and 3 months of age. PR-A levels were tenfold decrease with age. In conclusion, we have shown that the basal higher than those of PR-B in cell populations where PR-B was level of PR-A was increased in old rats, and that this correlated detectable; PR-B receptors were not detectable in all cell with increased serum estrogen levels, but not with the number populations.
    [Show full text]
  • Tolfenamic Acid and Meloxicam Both Provide an Adequate Degree of Postoperative Analgesia in Dogs Undergoing Ovariohysterectomy
    Veterinarni Medicina, 62, 2017 (06): 333–341 Original Paper doi: 10.17221/143/2016-VETMED Tolfenamic acid and meloxicam both provide an adequate degree of postoperative analgesia in dogs undergoing ovariohysterectomy X.Y. Hu, L. Luan, W. Guan, J. Shi, Y.B. Zhao, H.G. Fan* Department of Veterinary Surgery, College of Veterinary Medicine, Northeast Agricultural University, Harbin, China *Corresponding author: [email protected] ABSTRACT: This study was aimed at comparing the postoperative analgesic effects of tolfenamic acid and meloxi- cam in dogs undergoing ovariohysterectomy. Ovariohysterectomy was performed in 24 female dogs. All dogs were administered pre-anaesthetic medication comprised of 0.02 mg/kg i.m. acepromazine, and general anaesthesia was induced with i.v. propofol (4–6 mg/kg) and maintained with 1.5–2.0% isoflurane. Dogs were divided into three groups (n = 8). Following induction of anaesthesia, group C received 0.05 ml/kg sterile saline i.m.; group T received 4 mg/kg tolfenamic acid i.m.; group M received 0.2 mg/kg meloxicam s.c. Heart rate, respiratory rate, rectal tem- perature, mean arterial pressure and arterial oxygen saturation of haemoglobin were monitored intraoperatively. Pain was assessed using the short form of the Glasgow composite pain scale (SF-GCPS) by two observers who were blinded to the treatment groups; pain was assessed at the time of pre-medication (baseline), and at 2, 4, 6, 8, 12 and 24 h after extubation. Rescue analgesia (0.2 mg/kg i.m. methadone) was administered to any dog with an SF-GCPS score of greater than or equal to six during postoperative monitoring.
    [Show full text]